AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2022

Key Information As of 10/31/24

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $62.07 million
NAV $31.99
Fact Sheet View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 10/31/24

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,940,000
Number of Holdings 83
30-Day Median Bid-Ask Spread 0.37%

Distributions As of 10/31/24

30-Day SEC Yield 0.95%
Distribution Frequency Semi-Annually

ETF Prices As of 10/31/24

NAV $31.99 Daily Change -$0.43 -1.33%
Market Price $32.01 Daily Change -$0.53 -1.63%

Performance History

As of recent
(09/30/24)
As of recent
(09/30/24)
Fund NAV Market Price Index
1 Year 26.40% 27.20% 26.83%
3 Years 4.73% 5.07% 5.01%
5 Years 9.83% 9.72% 10.10%
Since Inception 10.37% 10.67% 10.66%
1 Year 29.26% 29.44% 29.78%
3 Years 3.48% 3.48% 3.76%
5 Years 8.10% 8.03% 8.38%
Since Inception 9.95% 10.23% 10.25%
Year-to-Date 15.27% 15.84% 15.54%
1 Month -1.21% -1.03% -1.16%
3 Months 8.95% 9.14% 9.11%
Since Inception 128.99% 134.39% 134.20%
Year-to-Date 12.59% 12.94% 12.93%
1 Month -2.32% -2.50% -2.26%
3 Months 2.96% 2.93% 3.10%
Since Inception 123.68% 128.54% 128.91%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 10/31/24

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.12 WELL WELLTOWER INC BYVYHH4 134.88 18,936 2,554,087.68
3.89 4519 JP CHUGAI PHARMA CO 6196408 48.19 50,049 2,411,683.31
3.37 BSX BOSTON SCIENTIFIC CORP 2113434 84.02 24,856 2,088,401.12
3.36 ABBV ABBVIE INC B92SR70 203.87 10,214 2,082,328.18
3.27 AMGN AMGEN INC 2023607 320.16 6,337 2,028,853.92
3.13 BMY BRISTOL-MYERS SQUIBB CO 2126335 55.77 34,833 1,942,636.41
3.12 UCB BB UCB SA 5596991 191.94 10,075 1,933,818.98
3.09 ALC SW ALCON INC BJT1GR5 92.03 20,840 1,917,945.18
3.01 LLY ELI LILLY & CO 2516152 829.74 2,253 1,869,404.22
3.01 RO SW ROCHE HOLDING AG-BR 7108918 339.08 5,509 1,867,975.95
2.99 MDT MEDTRONIC PLC BTN1Y11 89.25 20,823 1,858,452.75
2.96 JNJ JOHNSON & JOHNSON 2475833 159.86 11,499 1,838,230.14
2.84 SYK STRYKER CORP 2853688 356.28 4,941 1,760,379.48
2.82 AZN ASTRAZENECA PLC-SPONS ADR 2989044 71.15 24,637 1,752,922.55
2.51 REGN REGENERON PHARMACEUTICALS 2730190 838.20 1,859 1,558,213.80
2.45 NOVOB DC NOVO NORDISK A/S-B BP6KMJ1 111.08 13,712 1,523,100.93
2.40 4543 JP TERUMO CORP 6885074 19.33 77,093 1,490,236.92
2.39 068270 KS CELLTRION INC B0C5YV1 132.25 11,224 1,484,333.33
2.19 VTR VENTAS INC 2927925 65.49 20,767 1,360,030.83
2.02 EW EDWARDS LIFESCIENCES CORP 2567116 67.01 18,686 1,252,148.86
1.82 ZBH ZIMMER BIOMET HO 2783815 106.92 10,581 1,131,320.52
1.81 SOON SW SONOVA HOLDING AG-REG 7156036 364.52 3,078 1,121,990.98
1.78 4503 JP ASTELLAS PHARMA INC 6985383 11.79 93,490 1,101,994.39
1.75 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 131.84 8,218 1,083,441.66
1.63 SDZ SW SANDOZ GROUP AG BLPLD38 45.51 22,230 1,011,623.11
1.61 BGNE BEIGENE LTD-ADR BYYWPW6 202.64 4,941 1,001,244.24
1.46 UTHR UNITED THERAPEUTICS CORP 2430412 373.97 2,427 907,625.19
1.39 DXCM DEXCOM INC B0796X4 70.48 12,228 861,829.44
1.38 INCY INCYTE CORP 2471950 74.12 11,578 858,161.36
1.35 PODD INSULET CORP B1XGNW4 231.53 3,612 836,286.36
1.23 GMAB DC GENMAB A/S 4595739 223.36 3,413 762,341.57
1.15 3692 HK HANSOH PHARMACEU BJYKB72 2.33 306,643 715,489.82
1.04 EXAS EXACT SCIENCES CORP 2719951 68.93 9,372 646,011.96
1.02 DVA DAVITA INC 2898087 139.81 4,522 632,220.82
1.01 COH AU COCHLEAR LTD 6211798 185.51 3,379 626,834.25
0.99 NBIX NEUROCRINE BIOSC 2623911 120.27 5,129 616,864.83
0.95 FME GR FRESENIUS MEDICAL CARE AG 5129074 38.99 15,158 590,943.30
0.90 SN/ LN SMITH & NEPHEW PLC 0922320 12.36 45,171 558,089.67
0.87 OHI OMEGA HEALTHCARE 2043274 42.47 12,658 537,585.26
0.83 EXEL EXELIXIS INC 2576941 33.20 15,584 517,388.80
0.79 TFX TELEFLEX INC 2881407 201.06 2,426 487,771.56
0.73 ENSG ENSIGN GROUP INC/THE B1YWPP8 154.99 2,912 451,330.88
0.71 PHM SM PHARMA MAR SA BMW2GT8 76.59 5,746 440,099.77
0.68 DEMANT DC DEMANT A/S BZ01RF1 36.62 11,536 422,485.99
0.54 GKOS GLAUKOS CORP BYMWL19 132.25 2,543 336,311.75
0.53 HALO HALOZYME THERAPEUTICS INC 2975098 50.57 6,535 330,474.95
0.52 AMP IM AMPLIFON SPA B14NJ71 27.90 11,660 325,327.05
0.50 YPSN SW YPSOMED HOLDING AG-REG B02SWN8 443.51 703 311,785.01
0.47 MMSI MERIT MEDICAL SYSTEMS INC 2580555 98.66 2,981 294,105.46
0.45 MNKD MANNKIND CORP BF081J4 7.07 39,575 279,795.25
0.44 BPMC BLUEPRINT MEDICINES CORP BWY52P3 87.51 3,149 275,568.99
0.40 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 44.43 5,559 246,986.37
0.39 SBRA SABRA HEALTH CAR B5NLBP6 19.40 12,344 239,473.60
0.37 DNLI DENALI THERAPEUTICS INC BD2B4V0 25.96 8,880 230,524.80
0.36 NHI NATL HEALTH INVESTORS INC 2626125 76.65 2,889 221,441.85
0.35 NHC NATIONAL HEALTHCARE CORP 2139731 116.03 1,895 219,876.85
0.35 EMBC EMBECTA CORP BMXWYR1 14.08 15,456 217,620.48
0.35 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 12.35 17,539 216,666.01
0.35 ITGR INTEGER HOLDINGS CORP BD06LM7 124.25 1,721 213,834.25
0.34 CSH-U CN CHARTWELL RETIRE B8S8C94 11.23 18,561 208,385.99
0.33 LTC LTC PROPERTIES INC 2498788 38.20 5,290 202,078.00
0.31 8086 JP NIPRO CORP 6641599 9.27 20,649 191,476.86
0.30 RYM NZ RYMAN HEALTHCARE LTD 6161525 2.96 63,184 186,891.52
0.30 NVCR NOVOCURE LTD BYSS4X4 15.18 12,048 182,888.64
0.29 853 HK MICROPORT SCIENTIFIC CORP B676TW7 0.83 219,602 181,909.46
0.28 AED BB AEDIFICA B1G5XP1 64.11 2,731 175,077.41
0.28 AMED AMEDISYS INC 2024332 94.60 1,844 174,442.40
0.27 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.36 472,624 169,610.64
0.26 LIVN LIVANOVA PLC BYMT0J1 51.62 3,144 162,293.28
0.26 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.21 746,392 160,330.65
0.26 BKD BROOKDALE SR B0PZN33 6.27 25,533 160,091.91
0.25 TBPH THERAVANCE BIOPHARMA INC BMNDK09 8.24 19,038 156,873.12
0.25 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.62 248,389 153,038.60
0.24 GN DC GN STORE NORD A/S 4501093 19.41 7,771 150,839.94
0.23 ACAD ACADIA PHARMACEU 2713317 14.59 9,776 142,631.84
0.23 EKTAB SS ELEKTA AB-B SHS B0M42T2 5.99 23,276 139,437.82
0.22 ALEC ALECTOR INC BJ4LDC4 4.92 27,243 134,035.56
0.21 OTHER PAYABLE & RECEIVABLES 1.00 131,603 131,603.26
0.21 9229 JP SUNWELS CO LTD BNTYNB5 11.97 10,679 127,874.58
0.17 145720 KS DENTIUM CO LTD BF07GJ6 57.03 1,801 102,709.20
0.15 ATEC ALPHATEC HOLDINGS INC BD60BG7 7.85 12,139 95,291.15
0.13 AGL AGILON HEALTH INC BLR4TK4 2.55 31,921 81,398.55
0.08 2500 HK VENUS MEDTECH -H BL6V047 0.47 102,940 48,368.98
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.02
0.00 CANADIAN DOLLAR 1.00 0 -0.01
0.00 DANISH KRONE 0.15 -308 -44.84
0.00 SWISS FRANC 1.16 -1,261 -1,458.68
0.00 CASH 1.00 -2,207 -2,206.66
-0.01 EURO 1.09 -2,869 -3,114.69
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 09/30/24

Sector Weight (%)
Health Care 92.0
Real Estate 8.1

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Pharmaceuticals, Biotechnology & Life Sciences 48.3
Health Care Equipment & Services 39.2
Equity Real Estate Investment Trusts (REITs) 8.1
Pharmaceuticals, Biotechnology 4.4

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 52.2
Switzerland 12.0
Japan 8.2
Denmark 4.8
Britain 4.8
China 4.6
Belgium 3.2
Ireland 2.9
South Korea 2.7
Australia 1.1
Germany 1.0
Other 2.5

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 10/31/24

Return on Equity 13.10%
Weighted Avg. Market Cap 106,765 M
2023 2024
Price-to-earnings 27.24 26.93
Price-to-book value 3.66 3.39

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 10/31/24

Versus Beta
S&P 500 0.74
NASDAQ-100 0.48
MSCI EAFE 0.77
MSCI Emg. Mkts 0.52
Standard Deviation 16.10%

Source: new windowAltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.